Point72 Asia Singapore Pte. Ltd. Trims Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Point72 Asia Singapore Pte. Ltd. decreased its stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 68.0% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 12,955 shares of the company’s stock after selling 27,486 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in KORU Medical Systems were worth $35,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in KRMD. Aaron Wealth Advisors LLC bought a new stake in shares of KORU Medical Systems during the second quarter valued at about $28,000. Allspring Global Investments Holdings LLC purchased a new position in KORU Medical Systems during the second quarter valued at approximately $28,000. Legato Capital Management LLC bought a new stake in KORU Medical Systems during the 2nd quarter worth approximately $35,000. Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after purchasing an additional 26,860 shares in the last quarter. Finally, Lakewood Asset Management LLC boosted its holdings in KORU Medical Systems by 13.9% in the 2nd quarter. Lakewood Asset Management LLC now owns 68,225 shares of the company’s stock valued at $181,000 after purchasing an additional 8,300 shares during the period. Hedge funds and other institutional investors own 58.60% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Canaccord Genuity Group upped their price target on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Piper Sandler raised their price target on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday, November 14th. Finally, Craig Hallum upped their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th.

KORU Medical Systems Trading Up 4.4 %

NASDAQ KRMD opened at $3.80 on Friday. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock’s 50-day simple moving average is $3.01 and its two-hundred day simple moving average is $2.63. KORU Medical Systems, Inc. has a twelve month low of $1.98 and a twelve month high of $4.20. The company has a market capitalization of $174.19 million, a price-to-earnings ratio of -15.20 and a beta of 0.48.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.